QR-kod

Alternative consent methods used in the multinational, pragmatic, randomised clinical trial SafeBoosC-III

Abstract Background The process of obtaining prior informed consent for experimental treatment does not fit well into the clinical reality of acute and intensive care. The therapeutic window of interventions is often short, which may reduce the validity of the consent and the rate of enrolled partic...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphov: Maria Linander Vestager, Mathias Lühr Hansen, Gorm Greisen, the SafeBoosC-III trial group
Materialtyp: Artigo
Språk:Inglês
Utgiven: BMC 2024-04-01
Serie:Trials
Ämnen:
Länkar:https://doi.org/10.1186/s13063-024-08074-0
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!